Doctor profile · Federal record
Dr. Talat Kheshgi, M.D.
Specialist (CMS: Rheumatology) · Rheumatology Physician · Dallas, TX
- NPI 1053310755
- Accepts Medicare
- MIPS 36.1 / 100 · 2023
- 40 yrs in practice
- Female
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
8144 Walnut Hill Ln, Suite 800
Dallas, TX 752314388
(214) 540-0700
fax (214) 540-0701
Credentials & registration
- NPI registered
- July 2005 — 21 yrs on file
- Profile last updated
- December 21, 2020
- Year of graduation
- 1986 — 40 yrs since
- Specialty taxonomy
- 174400000X — NUCC code
- State license (1)
- Texas #K7312
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1053310755. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
50,695
Distinct HCPCS
10
Medicare allowed
$468,828
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0717 |
Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 40,400 | 15 | $5 | |
J0897 |
Injection, denosumab, 1 mg | 4,080 | 41 | $23 | |
80053 |
Blood test, comprehensive group of blood chemicals | 662 | 341 | $10 | |
85025 |
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 648 | 331 | $8 | |
36415 |
Insertion of needle into vein for collection of blood sample | 644 | 329 | $8 | |
85652 |
Red blood cell sedimentation rate, to detect inflammation, automated | 630 | 324 | $3 | |
86140 |
Measurement c-reactive protein for detection of infection or inflammation | 629 | 324 | $5 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 538 | 271 | $124 | |
82306 |
Vitamin d-3 level | 277 | 196 | $29 | |
96401 |
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 270 | 54 | $70 |
In context: peer comparison
Among 20 peers in Dallas Specialist, average services per provider: 599. This provider delivers 85× the peer median.Open Payments
Industry payments received
All-time total
$330
Transactions
13
Manufacturers
9
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| GlaxoSmithKline, LLC. | 4 | $85.58 | |
| Janssen Biotech, INC. | 1 | $59.52 | |
| Abbvie INC. | 2 | $53.01 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | 1 | $39.59 | |
| Ani Pharmaceuticals, INC. | 1 | $28.38 | |
| Kiniksa Pharmaceuticals International, Plc | 1 | $18.86 | |
| Genentech USA, INC. | 1 | $17.49 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $14.26 | |
| Pfizer INC. | 1 | $13.73 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,736
Patients
469
Total drug cost
$821,405
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate | Generic | 387 | 109 | $25,387 |
| Methotrexate (Methotrexate Sodium) | Brand | 326 | 89 | $13,253 |
| Prednisone | Generic | 253 | 65 | $2,426 |
| Alendronate Sodium | Generic | 159 | 49 | $1,790 |
| Meloxicam | Generic | 85 | 26 | $396 |
| Celecoxib | Generic | 74 | 21 | $1,648 |
| Gabapentin | Generic | 67 | 24 | $1,468 |
| Allopurinol | Generic | 62 | 19 | $1,226 |
| Enbrel Sureclick (Etanercept) | Brand | 54 | 0 | $444,008 |
| Folic Acid | Generic | 52 | 15 | $217 |
Hospital affiliations
Frequently asked questions
What is Dr. Talat Kheshgi's medical specialty?
Dr. Talat Kheshgi practices Specialist in Dallas, TX.
Where does Dr. Talat Kheshgi practice?
Dr. Talat Kheshgi practices at 8144 Walnut Hill Ln, Dallas, TX 752314388. Office phone: 2145400700.
What is Dr. Talat Kheshgi's NPI?
Dr. Talat Kheshgi's National Provider Identifier (NPI) is 1053310755, issued by NPPES.
Does Dr. Talat Kheshgi accept Medicare assignment?
Yes. Dr. Talat Kheshgi accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Talat Kheshgi commonly perform?
Top Medicare-reported procedures in 2023: Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0717); Injection, denosumab, 1 mg (HCPCS J0897); Blood test, comprehensive group of blood chemicals (HCPCS 80053). Source: CMS Medicare Physician & Other Practitioners file.